Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centre
Over 60% of Fabry disease patients are at lifetime risk of developing CKD, with a substantial risk of mortality, even with initially normal uACR and eGFR values.
Authors
- Karolina M. Stępień (ORCID: https://orcid.org/0000-0003-0148-6332)
- Fahmida Mannan (ORCID: https://orcid.org/0000-0002-3094-784X)
- Gisela Wilcox (ORCID: https://orcid.org/0000-0002-8953-2403)
- Éamon P McCarron (ORCID: https://orcid.org/0000-0003-3387-9210)
- Ryan Wiltshire
- Ana Jovanović (ORCID: https://orcid.org/0000-0002-1523-6580)
- Reena Sharma (ORCID: https://orcid.org/0000-0003-3334-8081)
- Rajkumar Chinnadurai (ORCID: https://orcid.org/0000-0003-3973-6595)
- Philip A. Kalra (ORCID: https://orcid.org/0000-0001-7652-1572)
- Jan Hansel (ORCID: https://orcid.org/0000-0003-2858-1313)
Institutions
- Manchester Academic Health Science Centre (GB)
- Salford Royal NHS Foundation Trust (GB)
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- Institute of Infection and Immunity (CA)
- Diabetes UK (GB)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1007/s40620-024-02170-9
- Citations
- 2
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.65
Funders
- National Institute for Health and Care Research
- British Heart Foundation